Try our Advanced Search for more refined results
Axicon Partners
-
Order | Filed: May 31, 2024 | Entered: May 31, 2024 United Therapeutics Corporation v. Liquidia Technologies, Inc.
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Order - Memorandum and Order
MEMORANDUM ORDER: Plaintiff's motion for preliminary injunction (D.I. 25 ) is DENIED (see Memorandum Order for further details). Ordered by Judge Richard G. Andrews on 5/31/2024. (nms)
-
Discovery | Filed: May 28, 2024 | Entered: May 28, 2024 United Therapeutics Corporation v. Liquidia Technologies, Inc.
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Notice of Service
NOTICE OF SERVICE of Plaintiff's First Set Of Requests For Production Of Documents And Things To Liquidia Technologies, Inc. (Nos. 1-17) - filed by United Therapeutics Corporation.(Flynn, Michael)
-
Misc | Filed: May 23, 2024 | Entered: May 23, 2024 United Therapeutics Corporation v. Liquidia Technologies, Inc.
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Claim Construction Chart
CLAIM Construction Chart by United Therapeutics Corporation. (Attachments: # 1 Exhibit B - U.S. Patent No. 11,826,327 (LIQ_PH-ILD_00002737), # 2 Exhibit C - UTC's Intrinsic Evidence, # 3 Exhibit D - Liquidia's Intrinsic Evidence)(Flynn, Michael)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login